{"public_id":"cl_2b9d6f15690da0aa47cc571fa815d0ef","status":"active","superseded_by_public_id":null,"corpus_id":92628053,"text":"The signature-associated gene sets are enriched in cancer-related pathways, including IL6/STAT3 signaling, TNFα signaling via NF-κB, IL2/STAT5 signaling, the p53 pathway, and the KRAS signaling pathway.","confidence":0.95,"paper":{"corpus_id":92628053,"title":"An autophagy‐related long non‐coding RNA signature for glioma","url":"https://sah.borca.ai/papers/92628053"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_c223f8e238a785399409748d9048b0ab","name":"IL6/STAT3 signaling","description":"A cancer-related signaling pathway involving interleukin 6 and STAT3.","types":["pathway"],"url":"https://sah.borca.ai/concepts/co_c223f8e238a785399409748d9048b0ab"},{"public_id":"co_d0a368d06e3328ef02f0beaf4f0f007a","name":"gene set enrichment analysis","description":"A computational method used to identify pathways enriched in the signature-related genes.","types":["analysis method"],"url":"https://sah.borca.ai/concepts/co_d0a368d06e3328ef02f0beaf4f0f007a"},{"public_id":"co_f8eac3328322896163f26ae65b07abb9","name":"KRAS signaling pathway","description":"A signaling pathway centered on KRAS-related oncogenic activity.","types":["pathway"],"url":"https://sah.borca.ai/concepts/co_f8eac3328322896163f26ae65b07abb9"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_2b9d6f15690da0aa47cc571fa815d0ef"}